Unscheduled bleeding on birth control is one of the most common side effects across nearly every hormonal method, from pills to implants to IUDs. It happens because synthetic hormones change the way your uterine lining builds up and sheds, and sometimes the lining doesn’t stabilize the way the method intends. The good news is that most bleeding settles on its own within a few months, but sometimes it signals something else going on that deserves attention.
Two Kinds of Bleeding, Two Different Causes
Not all bleeding on birth control is the same. The bleed you get during a placebo week or hormone-free interval is called withdrawal bleeding. It’s triggered by a sudden drop in hormone levels and is essentially the body’s response to losing hormonal support. This is the predictable, period-like bleed that most combined-pill users expect every month.
The bleeding that catches people off guard is breakthrough bleeding, sometimes called BTB. This is unscheduled bleeding that shows up while you’re still taking active hormones. Combined oral contraceptives can cause it when hormone levels fluctuate or the lining isn’t kept stable enough. Progestin-only methods tend to cause it through a different route: the continuous progestin exposure reshapes the uterine lining in ways that make it prone to fragile, unpredictable shedding.1PubMed Central. Understanding Problematic Bleeding When Using Contraception: Guidance for Clinicians Understanding which type you’re dealing with helps explain why the bleeding is happening and whether it’s likely to stop.
What Happens Inside the Uterine Lining
The uterine lining is a highly vascular tissue, rich with tiny blood vessels that are constantly being built and remodeled. In a natural menstrual cycle, rising estrogen thickens the lining, and progesterone stabilizes it after ovulation. When both hormones drop, the lining sheds in an organized way. Hormonal contraception interrupts this cycle, and the lining doesn’t always respond tidily.
With progestin-only methods in particular, the lining thins out over time and the blood vessels within it change. Research has found that in progestin-treated tissue, blood vessels become dilated and thin-walled, partly driven by a growth factor called VEGF-D that is produced when the tissue responds to progestin.2PubMed Central. Dilated thin-walled blood and lymphatic vessels in human endometrium: a potential role for VEGF-D in progestin-induced break-through bleeding These fragile vessels are more prone to leaking, which is why spotting or bleeding can happen seemingly at random.
The structural support around those vessels also weakens. In women using the Norplant implant who had breakthrough bleeding, the smooth muscle surrounding endometrial blood vessels was significantly reduced compared to implant users who didn’t bleed. About 60% of their vessels lacked this supportive casing, versus 46% in those without bleeding problems.3PubMed. Perivascular smooth muscle alpha-actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding Without that structural scaffolding, vessels are more likely to break down and bleed.
On top of all that, the tissue itself can actively break apart in spots. In endometrial samples from women experiencing breakthrough bleeding, researchers found areas where stromal tissue was locally dissolving, collagen fibers were being destroyed, and enzymes that chew up structural tissue were highly active. These same enzymes were essentially absent in tissue from women on progestin who were not bleeding.4PubMed. Temporal and spatial association of matrix metalloproteinases with focal endometrial breakdown and bleeding upon progestin-only contraception So breakthrough bleeding isn’t just vessels leaking passively; in some cases, the lining is actively breaking down in small patches.
How Each Method Affects Bleeding Differently
While the general mechanism involves the lining’s response to hormones, the specific pattern of bleeding depends a lot on which method you’re using.
Combined Pills
Breakthrough bleeding on combined pills is most common in the first one to three months. During this adjustment window, the lining hasn’t fully adapted to the hormone levels in your pill. Missing pills or taking them at inconsistent times makes it worse because even small dips in hormone levels can destabilize the lining enough to trigger spotting. Low-dose formulations with less estrogen also tend to have slightly higher rates of breakthrough bleeding because there’s less estrogen available to keep the lining thick and stable.
Progestin-Only Pills, Implants, and Injections
Methods that deliver only progestin create the vascular and tissue changes described above, and they tend to produce the most unpredictable bleeding patterns. With the etonogestrel implant (sold as Nexplanon), irregular bleeding is the top reason people ask to have it removed. The lining thins dramatically under continuous progestin, and the fragile vessels within it bleed without the organized shedding you’d get with a normal period. Surface changes have also been observed in implant users, including prominent glandular openings and small polyps on the uterine lining’s surface.5PubMed. Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants
Injectable contraception (like the depot medroxyprogesterone acetate shot) follows a similar trajectory. Bleeding is often erratic in the first few months, but over time many users actually stop bleeding altogether as the lining thins to the point where there’s almost nothing left to shed. Getting to that point can take six months or more, and some people never reach it.
Hormonal IUDs
The levonorgestrel-releasing IUD (brands like Mirena and Liletta) releases progestin directly into the uterus. Most users experience spotting or light bleeding for the first three to six months after insertion. In a trial looking at the early months after IUD placement, the median number of bleeding or spotting days over the treatment period was around 25 to 33 days, depending on the group.6Obstetrics & Gynecology. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial That can feel like a lot of bleeding, especially in the first few months. But most users see a significant reduction over time, and many eventually have very light periods or none at all.
Continuous or Extended Regimens
Skipping the placebo week to use pills, patches, or rings continuously is increasingly popular for people who want to avoid monthly bleeds entirely. It works well for many, but breakthrough bleeding can be more common in the early months compared to traditional cycling. In a trial of continuous vaginal ring use, most participants had minimal bleeding, and those who made it through the adjustment phase had bleeding-free days about 89% to 95% of the time.7PubMed. Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial The pattern is consistent across continuous-use methods: expect some erratic bleeding early, with improvement over the first few cycles.
When the Problem Isn’t Actually the Birth Control
One of the trickier aspects of bleeding on birth control is that the contraceptive itself isn’t always the cause. Several other conditions can produce unscheduled bleeding, and starting a new hormonal method sometimes masks or reveals them.
Infections
Cervical infections, particularly chlamydia, can cause intermenstrual spotting that looks identical to breakthrough bleeding from the pill. In one study, about 29% of women on oral contraceptives who had persistent spotting after more than three months of use tested positive for chlamydia, compared to roughly 11% of pill users tested for other reasons and only 6% of women screened before starting contraception.8PubMed Central. Chlamydia trachomatis in patients who used oral contraceptives and had intermenstrual spotting If bleeding persists beyond the typical three-month adjustment window, sexually transmitted infection screening is a reasonable step, especially if you have new or multiple partners.
Structural Issues
Uterine fibroids and polyps can cause heavy or irregular bleeding regardless of whether you’re on birth control. In women with fibroids, combined oral contraceptives may help control bleeding symptoms to some extent, but they don’t shrink the fibroids. One trial found that fibroid volume actually increased modestly even during oral contraceptive use.9PubMed. Efficacy of ormeloxifene versus oral contraceptive in the management of abnormal uterine bleeding due to uterine leiomyoma If you had heavy periods before starting birth control and the bleeding doesn’t improve as expected, an underlying structural cause is worth investigating with imaging.
Thyroid Problems
Thyroid dysfunction can disrupt menstrual patterns and mimic or amplify abnormal bleeding. In a study of women with abnormal uterine bleeding, about 16% had some form of thyroid dysfunction, with hypothyroidism being the most common.10Nepal Medical Association (JNMA). Thyroid Dysfunction in Patient with Abnormal Uterine Bleeding in a Tertiary Hospital of Eastern Nepal: A Descriptive Cross-sectional Study This doesn’t mean thyroid issues are a common cause of bleeding on birth control specifically, but if you have other symptoms of thyroid trouble (fatigue, weight changes, temperature sensitivity), it’s worth checking.
Lifestyle Factors That Make It Worse
Your body doesn’t process contraceptive hormones in a vacuum. Several everyday factors influence how well your method stabilizes the uterine lining.
Smoking is one of the clearest culprits. Cigarette smoking worsens cycle control among oral contraceptive users, likely because it speeds up the breakdown of estrogen in the body. With less circulating estrogen available, the lining is less stable and breakthrough bleeding becomes more likely.11PubMed. Smoking and cycle control among oral contraceptive users This is separate from the cardiovascular risks of smoking on combined contraceptives, which is the reason most clinicians strongly discourage that combination. But even from a bleeding standpoint, smoking works against you.
Body weight can also play a role. Higher body mass changes how hormones are distributed and metabolized, and some evidence suggests that contraceptive efficacy and cycle control may differ in people with higher BMIs. A Cochrane review found that with one combined pill formulation, pregnancy risk was higher for women with a BMI at or above 25 compared to those below that threshold.12Cochrane Library. Hormonal contraceptives for contraception in overweight or obese women While the relationship between weight, breakthrough bleeding, and contraceptive failure isn’t perfectly straightforward, the underlying pharmacokinetic principle is that the same dose of hormones may behave differently in different bodies. If you’re on a lower-dose method and experiencing persistent bleeding, it’s a factor worth discussing with your provider.
Consistency of use matters too. Taking pills at very different times each day, missing doses, or having gastrointestinal issues like vomiting or diarrhea shortly after taking a pill can all reduce the amount of hormone your body absorbs. These dips in hormone levels, even short-lived ones, can be enough to destabilize the lining and trigger spotting.
What You Can Do About It
The most effective treatment for breakthrough bleeding depends on the method causing it.
For combined pill users, the simplest fix is patience. Most breakthrough bleeding resolves within the first three cycles. If it doesn’t, switching to a pill with a slightly higher estrogen dose or a different progestin can help. Taking the pill at the same time every day, not skipping pills, and addressing any absorption issues (such as concurrent medications that affect hormone metabolism) can also improve things.
For hormonal IUD users, a trial tested whether non-hormonal medications could reduce the initial bleeding. Tranexamic acid (a medication that helps blood clot) reduced bleeding and spotting days by about 6 days compared to placebo, which was a modest but real improvement. Mefenamic acid, an anti-inflammatory, had a smaller and not statistically significant effect.6Obstetrics & Gynecology. Management of initial bleeding or spotting after levonorgestrel-releasing intrauterine system placement: a randomized controlled trial Some providers recommend ibuprofen for similar reasons, though the evidence specifically for IUD-related bleeding is limited.
For implant users dealing with prolonged bleeding, adding a short course of a progestin pill can be effective. A randomized trial found that about 87% of women with prolonged bleeding on the etonogestrel implant stopped bleeding within 7 days of starting norethisterone acetate (a progestin pill), compared to about 49% on placebo. Those who took the progestin pill also had more bleeding-free days in the following month, about 21 days versus 13 days.13American Journal of Obstetrics and Gynecology. Norethisterone for prolonged uterine bleeding associated with etonogestrel implant (IMPLANET): a randomized controlled trial The trade-off is that bleeding tends to come back sooner after stopping the treatment compared to placebo, but the net result is still more bleeding-free time overall.
Regardless of method, you should bring up persistent bleeding with your provider rather than just stopping the method on your own. Unscheduled bleeding is one of the top reasons people discontinue their birth control, which often leads to unintended pregnancy.14PubMed Central. Unscheduled bleeding and contraceptive choice: increasing satisfaction and continuation rates A conversation about what’s causing the bleeding and whether a simple adjustment could fix it is almost always more useful than abandoning the method.
When Bleeding on Birth Control Needs Medical Attention
Most breakthrough bleeding is a nuisance, not a danger. But some patterns warrant prompt evaluation. Heavy bleeding that soaks through a pad or tampon every hour for several hours is not typical breakthrough bleeding on any method. Neither is bleeding accompanied by fever, pelvic pain, or foul-smelling discharge, which could suggest infection. Bleeding that begins after a long period of no problems on the same method is also worth investigating, because a new onset of bleeding after months or years of stability can signal a structural change, an infection, or, rarely, a cervical or endometrial problem that needs evaluation.
If you’re on a combined method and develop sudden severe headaches, visual changes, or leg pain alongside unusual bleeding, those are symptoms of more serious complications like blood clots and need immediate medical attention. These aren’t caused by the bleeding itself, but the fact that you’re noticing something unusual with your method is a reason to pay closer attention to other symptoms as well.
The Three-Month Rule and Its Limits
You’ll hear the “give it three months” advice from nearly every clinician, and it’s grounded in real patterns. Most hormonal methods do show their worst bleeding behavior in the first 90 days, and most improve after that. But the rule has limits. Three months is an average, not a guarantee. Some people take longer, and some never fully adjust to a given method. If you’re on month four or five and still bleeding frequently, it doesn’t mean something is wrong with you, but it does mean the method may not be the right fit. Switching to a different pill, moving from a progestin-only method to a combined one (or vice versa), or trying a different delivery route (ring instead of pill, or IUD instead of implant) can make a significant difference because each formulation and route creates a slightly different hormonal environment in the uterine lining.
The frustrating reality is that there’s no reliable way to predict who will bleed on which method before trying it. Researchers haven’t identified a biomarker or clinical feature that consistently predicts who will have a smooth transition and who will spend months spotting. The process remains, to a large degree, trial and adjustment.
Drug Interactions That Can Trigger Bleeding
Certain medications interfere with how your body processes contraceptive hormones, effectively lowering the hormone levels in your blood even when you’re taking the pill correctly. The most well-known culprits are enzyme-inducing drugs: some anti-seizure medications (like carbamazepine and phenytoin), the antibiotic rifampin (used for tuberculosis), and the herbal supplement St. John’s wort. These substances ramp up liver enzymes that break down estrogen and progestins faster than normal, reducing circulating hormone levels and destabilizing the uterine lining.
The effect of other common antibiotics on birth control is often overstated. Outside of rifampin, most standard antibiotics (like amoxicillin or azithromycin) don’t meaningfully reduce contraceptive hormone levels. If you start a new medication and notice breakthrough bleeding within a few weeks, check whether it’s on the list of drugs known to interact with hormonal contraception. Your pharmacist can usually answer this quickly.
Antiretroviral medications used for HIV treatment or pre-exposure prophylaxis (PrEP) can also interact with some contraceptive hormones, though the interactions vary by specific drug. If you’re on both, it’s important to verify compatibility with a provider who knows both your regimens.